Publications by authors named "Stuart Holden"

Claim this Profile
U
Utilization of a Third-party Partnership in Tele-genetic Risk Assessment Program in Genitourinary Oncology.
Lin Lin, Eric Lu, Josh Yurasits, Joanna Mercado, Megan Myers, Stuart Holden

Urology· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial.
Thomas A Hope, Matthias Eiber, Wesley R Armstrong, Roxanna Juarez, Vishnu Murthy, Stuart Holden

JAMA Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate Cancer Pulmonary Metastasis Presenting as a Ground-Glass Pulmonary Nodule on 68Ga-PSMA-11 PET/CT.
David J Lubin, Stuart B Holden, Matthew B Rettig, Robert E Reiter, Christopher R King

Clin Nucl Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate Cancer Screening and the Goldilocks Principle: How Much Is Just Right?
Izak Faiena, Stuart Holden, Mathew R Cooperberg, Stuart Holden, Howard R Soule

J Clin Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRI-guided Dose-escalated Salvage Radiotherapy for Bulky Bladder Neck Recurrence of Prostate Cancer.
Amar U Kishan, Marguerite Tyran, Michael L Steinberg, Stuart B Holden, Minsong Cao

Cureus· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serial retrograde instillations of sustained release formulation of mitomycin C to the upper urinary tract of the Yorkshire swine using a thermosensitive polymer: Safety and feasibility.
Nicholas M Donin, Dalit Strauss-Ayali, Yael Agmon-Gerstein, Nadav Malchi, Andrew T Lenis, Stuart Holden

Urol Oncol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of TMX-101, intravesical imiquimod, for the treatment of carcinoma in situ bladder cancer.
Nicholas M Donin, Karim Chamie, Andrew T Lenis, Allan J Pantuck, Madhu Reddy, Stuart Holden

Urol Oncol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for the Treatment of Urothelial Carcinoma.
Nicholas M Donin, Andrew T Lenis, Stuart Holden, Alexandra Drakaki, Allan Pantuck

J Urol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained-release Formulation of Mitomycin C to the Upper Urinary Tract Using a Thermosensitive Polymer: A Preclinical Study.
Nicholas M Donin, Sandra Duarte, Andrew T Lenis, Randy Caliliw, Cristobal Torres, Stuart Holden

Urology· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active surveillance for prostate cancer: the role of the pathologist.
Brett Delahunt, Elizabeth Hammond, Lars Egevad, Hemamali Samaratunga, John R Srigley, Stuart Holden

Pathology· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist.
Rodolfo Montironi, Elizabeth H Hammond, Daniel W Lin, John L Gore, John R Srigley, Stuart Holden

Virchows Arch· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation.
Mahul B Amin, Daniel W Lin, John L Gore, John R Srigley, Hema Samaratunga, Stuart Holden

Arch Pathol Lab Med· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The integrated proactive surveillance system for prostate cancer.
Haibin Wang, Mahendra Yatawara, Shao-Chi Huang, Kevin Dudley, Christine Szekely, Stuart Holden

Open Med Inform J· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Raloxifene, an oestrogen-receptor-beta-targeted therapy, inhibits androgen-independent prostate cancer growth: results from preclinical studies and a pilot phase II clinical trial.
Ronald L Shazer, Anjali Jain, Anna V Galkin, Nadya Cinman, Koo N Nguyen, Stuart Holden

BJU Int· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of HER-kinase activation prevents ERK-mediated degradation of PPARgamma.
Michael Hedvat, Anjali Jain, Dennis A Carson, Lorenzo M Leoni, Ganghua Huang, Stuart Holden

Cancer Cell· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis